nExodigm develops extracellular sensors that monitor intracellular genomic and transcriptomic content in living cells. This technology enables researchers to select, track, and study specific cells based on their genomic content for various research applications. By providing real-time genomic information, nExodigm ensures researchers work with the precise cells they need.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for monitoring intracellular genomic and transcriptomic content in living cells are invasive and lack real-time capabilities. This makes it difficult for researchers to select, track, and study specific cells based on their dynamic genomic profiles. The inability to continuously monitor cellular changes limits the understanding of cellular behavior in basic, translational, and clinical research.
Solution
Exodigm is developing extracellular organic sensors that enable real-time monitoring of intracellular genomic and transcriptomic content in living cells without disrupting cellular integrity. This technology allows researchers to select, track, and study specific cells based on their genomic content for various downstream applications. By providing continuous genomic information, Exodigm ensures researchers can work with the precise cells they need and observe their dynamic changes over time. This approach facilitates a deeper understanding of cellular processes and responses in various research settings.
Target Audience
The primary audience includes researchers in basic science, translational medicine, and clinical research who require real-time monitoring of cellular genomic content.
Features
- Extracellular organic sensors for non-invasive monitoring of intracellular genomic and transcriptomic content.
- Real-time data acquisition enabling continuous tracking of cellular changes.
- Capability to select and isolate specific cells based on their genomic profiles.
- Applications in basic, translational, and clinical research.